Med by Cell Press’ Post

Doctor CPD | External Accreditation Module | Bladder cancer in review, latest approaches to management (RCPI Ref 1046) #Bladdercancer #cpdireland #doctorcpd #medilearning https://ow.ly/plkl50Qaq7q

#ClinicalTrials: More than just testing treatments! While some participants may not directly benefit, many join clinical research for a powerful reason: to advance medical science and improve healthcare for the future. They are the heroes who pave the way for better treatments. Reasons people join clinical trials: - Help others with the same condition. - Gain access to potentially groundbreaking treatments. - Contribute to medical knowledge. - Receive close monitoring from healthcare professionals. Learn more: https://lnkd.in/e4eWSnZu #SciTechSDP #CutaneousLymphoma #CLF #PatientSupport #scitechSDP #scitechdevelopment #oncology #nanofenretinide #fenretinide #lymphoma #nonhodgkin #drugdelivery #ST001

External Credit Doctor CPD Module | Bladder cancer in review, latest approaches to management (RCPI Ref 1046). #Bladdercancer #cpdmodule #externalcredit #irishcpdmodule #healthcarecpdmodule #doctorcpd Start Learning - https://lnkd.in/eHxz4iS9

🧐Chemotherapy is a totalizing zeitgeber. The impact of chemo on lived temporal experience is independent of the type of cancer, the length of treatment, and the sociodemographic background✅ 👏by Marcin Moskalewicz et al. IDEAS NCBR Find the full paper here↘️ https://lnkd.in/em-cpudg

NEW from #ASCOGU 2024 | #Sacituzumab govitecan and other ADCs in #prostatecancer 🇺🇸 🎥 Umang Swami, MD, MS, University of Utah School of Medicine, comments on the various #antibodydrugconjugates (ADCs) being investigated for #prostatecancer, including #sacituzumabgovitecan The ADC consists of a trop-2-directed #antibody linked to SN-38, the payload. Dr Swami additionally highlights nectin-4-directed antibodies in #clinical trials💡 Take a look 👉 https://lnkd.in/eGDPnMmR #VJOncology #PCsm

Thanks to Medical Laboratory Observer for sharing our decision impact study news! 🔬 Choosing the right therapy for metastatic #NSCLC is complex, with new #biomarkers continuing to evolve in clinical practice. Our study demonstrates how the PROphetNSCLC test, a plasma #proteomics machine learning-based assay, can significantly impact oncologists' treatment choices, especially when combined with PD-L1 expression. Read more: https://lnkd.in/dJfXvfh6

Interesting watch here surrounding recent approvals of CAR-T Cell Therapy in R/R Multiple Myeloma. Kudos to Caitlin Costello for the video! #cancer #cart #immonology #oncology #science #myeloma https://lnkd.in/eJsYsDth

Discover our most watched webinar and learn groundbreaking insights from Prof. Marcela Maus. 🔬📺 Watch this webinar to learn about novel CAR-T developments and the use of avidity to understand and enhance productive CAR-T cell interactions with both liquid and solid tumors from Dr. Marcela Maus, Director of cellular immunotherapy at Harvard Medical school. Check out Prof. Marcela Maus' highlighted webinar here: https://bit.ly/3RPrMz4

In healthcare, long-term relationships create synergies to improve patient health.    Siemens Healthineers is pleased to be building on our 40-year history of clinical and research collaboration with University Hospitals, entering a new 10-year strategic alliance. In this ambitious next phase, we’ll focus on improving oncology, cardiovascular, and neurovascular care for patients in Ohio. Together, we’ll look to advance the treatment of Alzheimer’s patients and use theranostics – which combines diagnostics and therapeutics – to treat patients with advanced forms of cancer. We’re excited to leverage our innovative technology and solutions to dramatically impact patients facing serious medical conditions. https://lnkd.in/ex63vdEE  #betterpatientcare #researchandcollaboration 

 Dive into our services! At Atticus Healthcare, we're in 4 critical areas : - New Launch Guidance - Research and Analytics - Medical Education - Field Force Empowerment Ready to elevate your strategies? Contact us today! Sagar Sharma Partho Sarathi Ghosh #atticushealthcare #pharmaconsulting #oncology #biosimilars